Pfizer’s Covid-19 pill gets U.S. FDA clearance
Pfizer raises production projections from 80 million to 120 million courses of treatment in 2022, as a result of continued investments to support the manufacturing and distribution of Paxlovid
Pfizer raises production projections from 80 million to 120 million courses of treatment in 2022, as a result of continued investments to support the manufacturing and distribution of Paxlovid
The VaxIT app, developed on the Salesforce platform for Azim Premji Foundation and its partners, captures the status of vaccinations to help individuals plan and stay updated on their progress
Medical footprint expansion with deeper medical grade skin contact material science expertise
While continuing to offer its current breadth of genomic services, Biogazelle will become CellCarta's Center of Excellence for the development of complex genomic biomarker assays
Collaboration aims to develop innovative machine learning and artificial intelligence solutions for personalized and earlier treatment in neurology
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants
The platform’s technology works as a compression algorithm for molecular testing
It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time
Subscribe To Our Newsletter & Stay Updated